FEC (forward-error-correction) techniques correct errors at the receiver end of digital communications systems. In contrast with error-detection and retransmission ...

Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

Abstract: In-memory computing (IMC) architecture emerges as a promising paradigm, improving the energy efficiency of multiply-and-accumulate (MAC) operations within deep neural networks (DNNs) by ...

The NBA has revamped the format for the annual All-Star Game again. The league has tried to drum up some more interest from fans and players alike to create a more intriguing event. Last year, that ...

A complement C4 (also known as a complement component 4, or simply C4) is a test to measure the level of C4 proteins you have in your blood. These proteins play a role in how your immune system ...

Boycott Heaven, The Format's first studio album in nearly 20 years, arrives today. For a while, the indie rock outfit's Sam Means and Nate Ruess thought they might be cursed as a band. "Anytime we get ...

NASCAR has announced a return to The Chase championship format for all three national series beginning in 2026, with a modified structure from the previous iteration designed to reward performance ...

Abstract: Inexact arithmetic units trade precision for improvements in energy efficiency, silicon area, and speed. Most existing designs focus on non-negative numbers and, when used in real ...

Struggling to draft the perfect job application letter? You’re not alone. In a competitive job market, your application letter is more than just a formality, it’s your first chance to impress a ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...